- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
John C. Richter
News 14 results
Recognition
October 28, 2025
Benchmark Litigation Recognizes King & Spalding as a Leading Litigation Firm
Recognition
June 11, 2025
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2025 Guide
Recognition
October 9, 2024
Benchmark Litigation Recognizes King & Spalding as a Leading Litigation Firm
Recognition
September 19, 2024
King & Spalding Earns Multiple Rankings in LMG Life Sciences 2024 Guide
Events 12 results
Conference
November 4, 2025
King & Spalding Pharmaceutical University 2025
Conference
September 4, 2025
18th Annual King & Spalding Medical Device Summit
Conference
September 5, 2024
17th Annual King & Spalding Medical Device Summit
Speaking Engagement
January 24, 2024
John Richter to Speak at 17th Forum on Foreign Corrupt Practices Act
Insights 21 results
Client Alert
March 3, 2026
COPPA Meets Reality: The FTC Signals a New Approach to Age Verification
Client Alert
January 9, 2026
Leveraging the False Claims Act to Target Corporate DEI Programs
Client Alert
June 12, 2025
A New Era of FCPA Enforcement
Client Alert
March 11, 2025
Recent Decisions and DOJ Policy Announcements Signal Key Changes to FCA Enforcement and Litigation Environment